Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Digital patient experiences are enhanced to connect with individuals during their most crucial moments. By offering tailored solutions that resonate with each patient’s unique needs and providing essential support, the aim is to foster personal engagement that aids patients throughout their treatment journey. It is vital to maintain transparency and guidance during what can be an overwhelming process. Through an integrated platform, digital connectivity ensures real-time support, keeping every patient’s care network aligned throughout their treatment experience. Patients benefit from comprehensive treatment management that combines cutting-edge technology with expert knowledge. Data-driven insights fuel an innovative digital platform that promotes human engagement, ultimately delivering a holistic care experience. Our digital solution addresses a significant need by educating, reminding, and coaching both patients and caregivers at every step of the treatment journey. Additionally, JITI technology takes a proactive approach by intervening with patients to enhance their engagement and support. By prioritizing these elements, we aim to improve overall patient satisfaction and outcomes during challenging times.
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
Free
Free Trial
No
Free Version
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
Yes
Android App
Yes
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
Yes
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Medisafe
Country
United States
Website
www.medisafe.com/solutions/
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/
Product Features
Patient Engagement
Appointment Scheduling
No
Care Planning
No
Collaboration
No
Messaging
No
Mobile Access
No
Patient Education
No
Patient Portal
No
Personal Health Record
No
Progress Tracking
No
Self Management
No